Phocas Financial Corp.

Position in PCRX — Pacira BioSciences, Inc.

CIK 1356783 ALAMEDA, CA

Position in PCRX

as of Mar 31, 2026 · filed May 1, 2026 Compact

Position Value

$2,585,733

-$1,206,592 QoQ

Shares Held

114,413

-21.9% QoQ

Ownership

0.291%

of shares outstanding

% of Portfolio

0.41%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 16.258641937542063.ToString("F0")% Shared 0.ToString("F0")% None 83.74135806245793.ToString("F0")%

Healthcare · as of Mar 31, 2026

Phocas Financial Corp. holds $23,598,730 across 5 Drug Manufacturers - Specialty & Generic names. PCRX ranks #4 (11.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMRX	Amneal Pharmaceuticals, Inc.	1,002,664	$12,463,113
2	ELAN	Elanco Animal Health Inc	142,521	$3,410,527
3	SUPN	Supernus Pharmaceuticals, Inc.	63,413	$3,277,817
4	PCRX	Pacira BioSciences, Inc. This page	114,413	$2,585,733
5	BCRX	Biocryst Pharmaceuticals Inc	195,540	$1,861,540

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,585,733	114,413	-21.9%	Shares	Sole	2026-05-01
2025-12-31	$3,792,325	146,535	-0.3%	Shares	Sole	2026-01-26
2025-09-30	$3,785,690	146,903	-24.1%	Shares	Sole	2025-11-12
2025-06-30	$4,623,144	193,437	+35.8%	Shares	Sole	2025-08-06
2025-03-31	$3,539,708	142,443	+222.8%	Shares	Sole	2025-05-09
2023-09-30	$1,353,939	44,131	-66.9%	Shares	Sole	2023-10-10
2023-06-30	$5,337,123	133,195	+38.2%	Shares	Sole	2023-07-13
2023-03-31	$3,932,288	96,356	+1.0%	Shares	Sole	2023-04-13
2022-12-31	$3,683,934	95,414	-0.0%	Shares	Sole	2023-01-11
2022-09-30	$5,076,613	95,443	+3.3%	Shares	Sole	2022-10-14
2022-06-30	$5,387,794	92,415	-1.1%	Shares	Sole	2022-08-15
2022-03-31	$7,131,951	93,448	—	Shares	Sole	2022-05-25
No filing history on record for this holder in this stock.